Change search
ReferencesLink to record
Permanent link

Direct link
Molecular signatures of T-cell inhibition in HIV-1 infection
Linköping University, Department of Clinical and Experimental Medicine, Molecular Virology. Linköping University, Faculty of Health Sciences.
University of Malaya, Malaysia .
Karolinska Institute, Sweden .
University of Malaya, Malaysia .
Show others and affiliations
2013 (English)In: Retrovirology, ISSN 1742-4690, Vol. 10, no 1Article, review/survey (Refereed) Published
Abstract [en]

Cellular immune responses play a crucial role in the control of viral replication in HIV-infected individuals. However, the virus succeeds in exploiting the immune system to its advantage and therefore, the host ultimately fails to control the virus leading to development of terminal AIDS. The virus adopts numerous evasion mechanisms to hijack the host immune system. We and others recently described the expression of inhibitory molecules on T cells as a contributing factor for suboptimal T-cell responses in HIV infection both in vitro and in vivo. The expression of these molecules that negatively impacts the normal functions of the host immune armory and the underlying signaling pathways associated with their enhanced expression need to be discussed. Targets to restrain the expression of these molecular markers of immune inhibition is likely to contribute to development of therapeutic interventions that augment the functionality of host immune cells leading to improved immune control of HIV infection. In this review, we focus on the functions of inhibitory molecules that are expressed or secreted following HIV infection such as BTLA, CTLA-4, CD160, IDO, KLRG1, LAG-3, LILRB1, PD-1, TRAIL, TIM-3, and regulatory cytokines, and highlight their significance in immune inhibition. We also highlight the ensemble of transcriptional factors such as BATF, BLIMP-1/PRDM1, FoxP3, DTX1 and molecular pathways that facilitate the recruitment and differentiation of suppressor T cells in response to HIV infection.

Place, publisher, year, edition, pages
BioMed Central , 2013. Vol. 10, no 1
Keyword [en]
BLIMP-1, CTLA-4, FoxP3, HIV-1, T-cell inhibition, LAG-3, PD-1, TIM-3, 2B4, CD160
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-91936DOI: 10.1186/1742-4690-10-31ISI: 000317060700001OAI: diva2:619782

Funding Agencies|University of Malaya Research Grant (UMRG) of the Health and Translational Medicine Research Cluster, University of Malaya, Kuala Lumpur|RG448-12HTM|Swedish Research Council||Swedish Physicians against AIDS Research Foundation||Swedish International Development Cooperation Agency||SIDA SARC||VINNMER for Vinnova||Linkping University Hospital Research Fund||CALF||Swedish Society of Medicine||Ministry of Higher Education Malaysia, High Impact Research Grant|HIRGA E000001-20001||AI52731|

Available from: 2013-05-06 Created: 2013-05-06 Last updated: 2014-11-25

Open Access in DiVA

fulltext(983 kB)142 downloads
File information
File name FULLTEXT01.pdfFile size 983 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Larsson, MarieEllegård, Rada
By organisation
Molecular VirologyFaculty of Health Sciences
In the same journal
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 142 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 56 hits
ReferencesLink to record
Permanent link

Direct link